Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report) Director Rodney Windley sold 180,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $11.50, for a total transaction of $2,070,000.00. Following the sale, the director owned 2,078,017 shares in the company, valued at approximately $23,897,195.50. The trade was a 7.97% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
Aveanna Healthcare Price Performance
Shares of NASDAQ:AVAH opened at $13.59 on Wednesday. The company has a market capitalization of $2.97 billion, a P/E ratio of 11.05, a P/E/G ratio of 0.96 and a beta of 1.90. Aveanna Healthcare Holdings Inc. has a 1-year low of $5.93 and a 1-year high of $13.98. The firm’s 50 day simple moving average is $9.83 and its two-hundred day simple moving average is $7.99. The company has a debt-to-equity ratio of 4.47, a current ratio of 1.16 and a quick ratio of 1.16.
Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) last announced its quarterly earnings data on Thursday, August 13th. The company reported $0.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.17 by $0.05. The firm had revenue of $670.48 million during the quarter, compared to analysts’ expectations of $638.61 million. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. Research analysts expect that Aveanna Healthcare Holdings Inc. will post 0.68 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Get Our Latest Research Report on AVAH
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in AVAH. Caitong International Asset Management Co. Ltd increased its holdings in shares of Aveanna Healthcare by 252.4% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock worth $27,000 after purchasing an additional 2,400 shares during the last quarter. Quantbot Technologies LP purchased a new position in Aveanna Healthcare during the 2nd quarter valued at approximately $43,000. Summit Securities Group LLC purchased a new position in Aveanna Healthcare during the 1st quarter valued at approximately $53,000. Oxford Asset Management LLP bought a new stake in Aveanna Healthcare in the 2nd quarter worth approximately $64,000. Finally, C M Bidwell & Associates Ltd. bought a new stake in Aveanna Healthcare in the 2nd quarter worth approximately $69,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.
Key Headlines Impacting Aveanna Healthcare
Here are the key news stories impacting Aveanna Healthcare this week:
- Positive Sentiment: Royal Bank of Canada raised its price target to $16 from $10 and upgraded AVAH to “outperform.” The upgrade reinforces the bullish outlook following the stock’s recent rally. Benzinga analyst coverage
- Positive Sentiment: Truist Financial increased its price target to $15 from $11, although it maintained a “hold” rating. Other analysts have also raised targets after Aveanna exceeded quarterly earnings and revenue expectations. Benzinga analyst coverage
- Positive Sentiment: Aveanna reported quarterly EPS of $0.22 versus the $0.17 consensus estimate and revenue of $670.48 million versus expectations of $638.61 million. The earnings beat supports the improved analyst outlook and investor interest in the shares.
- Neutral Sentiment: Management will participate in the Jefferies Healthcare Services and Technology Conference on September 15. The presentation and one-on-one investor meetings could provide additional business updates, but the event is not an immediate financial catalyst. Aveanna conference announcement
- Negative Sentiment: Major shareholders, including Bain Capital- and J.H. Whitney-affiliated holders, disclosed substantial sales in a roughly $176 million offering. Additional sales by CEO Jeff Shaner, director Rodney Windley, and insider Edwin Reisz at $11.50 per share could weigh on sentiment and increase concerns about selling pressure, even though these holders retained sizable positions. Home Health Care News offering report
Aveanna Healthcare Company Profile
Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.
In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.
Read More
- Five stocks we like better than Aveanna Healthcare
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
